Business Context and Reporting Period
Company: Chemical & Mining Co of Chile Inc (SQM)
Filing Type: Form 6-K (Earnings Release)
Reporting Period: Twelve months ended December 31, 2024 (Full Year 2024) and Fourth Quarter 2024.
Business Overview: SQM is a global producer of lithium, iodine, specialty plant nutrition (SPN), potassium, and industrial chemicals. The company reported record sales volumes in lithium and iodine but faced significant price declines in the lithium sector.
Key Financial Metrics
| Metric | Full Year 2024 | Full Year 2023 | Change |
|---|---|---|---|
| Total Revenues | US$4,528.8 million | US$7,467.5 million | (39.4%) |
| Net Income (Loss) | (US$404.4) million | US$2,012.7 million | Turned to Loss |
| Net Income per Share | (US$1.42) | US$7.05 | N/A |
| Gross Profit | US$1,327.1 million | US$3,075.1 million | (56.8%) |
| Gross Margin | 29.3% | 41.2% | (11.9) pts |
| Adjusted EBITDA | US$1,483.6 million | US$3,180.1 million | (53.4%) |
| Adjusted EBITDA Margin | 32.8% | 42.6% | (9.8) pts |
| Capital Expenditures | US$1.6 billion | N/A | N/A |
| Cash and Equivalents | US$1,377.9 million | US$1,041.4 million | +32.3% |
| Total Debt (Short + Long) | US$4,764.1 million | US$4,469.9 million | +6.6% |
| Liquidity Ratio | 2.5 | 2.5 | Flat |
Material Changes vs. Prior Period
- Lithium Segment: Revenues plummeted 56.7% to US$2,241.3 million. While sales volumes increased 21% (204.9k MT LCE), the average realized price collapsed 64% from US$30,467/ton to US$10,936/ton.
- Specialty Plant Nutrition (SPN): Revenues grew 3% to US$941.9 million, driven by a 17% volume increase that offset a 12% price decline.
- Iodine Segment: Revenues increased 8.5% to US$968.3 million with record sales volumes (14.5k MT) and quarter-over-quarter price increases.
- Potassium Segment: Full-year revenues decreased 3% to US$270.8 million despite a 28% volume increase, due to lower market prices. Q4 revenues rose 30% year-over-year.
- Industrial Chemicals: Revenues dropped 55.4% to US$78.2 million due to significantly lower sales volumes.
- Tax Impact: A specific tax on mining activities in Chile regarding lithium exploitation resulted in a US$1,106.2 million tax expense, significantly impacting net income.
Guidance, Outlook, and Risks
Management Commentary and Outlook
- Lithium: Management expects global demand to grow ~17% in 2025. SQM anticipates a 15% increase in sales volumes but expects average realized prices to remain lower than 2024 levels, with a positive trend potentially starting in 2026.
- Iodine: Prices are expected to remain stable or increase in Q1 2025 due to limited supply. Market demand growth is projected at ~2% for 2025.
- SPN: Market growth of 4-5% is anticipated for 2025 with stable prices. Sales volumes are expected to increase in line with market growth.
- Potassium: Sales volumes are expected to drop ~50% in 2025 as the company prioritizes lithium brine extraction and uses potassium chloride as feedstock for SPN production.
- Capex: 2025 capital expenditure is guided at approximately US$1.1 billion, allocated to Lithium (US$550m), Iodine/SPN (US$350m), and International Lithium (US$200m).
Risks and Contingencies
- Regulatory/Tax Risk: SQM is actively contesting the Chilean Internal Revenue Service's application of a specific mining tax to lithium extraction, arguing lithium is not a concessionable substance. The company has recognized a US$1,106.2 million expense related to this dispute.
- Market Volatility: Continued price declines in lithium and industrial chemicals pose a risk to revenue stability despite volume growth.
- Operational Execution: Risks associated with ramping up new facilities (Mt. Holland, Kwinana refinery) and expansion projects in Chile.
Investor Verification Checklist
- Tax Dispute Status: Verify the current legal standing of the US$1.1 billion specific mining tax claim and potential for reversal or additional liabilities.
- Lithium Price Trajectory: Monitor spot and contract lithium prices to validate management's assumption of stable-to-lower prices in 2025 and the 2026 recovery timeline.
- Capital Allocation: Confirm the progress and cost adherence of the US$1.1 billion 2025 Capex plan, specifically the Mt. Holland ramp-up and Kwinana refinery commissioning.
- Potassium Strategy: Assess the impact of the planned 50% reduction in potassium sales volumes on overall revenue mix and cash flow.
- Working Capital: Review inventory levels (US$1.7 billion) and accounts receivable trends given the significant revenue contraction.